Transgenic mice with overexpression of NPY are more prone to doxorubicin mediated cardiomyopathy, whereas NPY knockout rats have improved cardiac function and reduced apoptosis following MI (Huang et al., 2019). This evidence concerns the gene NPY and cardiomyopathy.